Table 2.
The comparison of selected demographic and tumor related characteristics between metastatic and synchronous endometrial disorder and other epithelial ovarian cancer
| Characteristics | Metastatic (N = 136) | Others (N = 211) | P-valuea | Synchronous (N = 37) | P-valueb |
|---|---|---|---|---|---|
| Age, yrs. | 52.32 ± 11.24 | 50.65 ± 11.43 | 0.182 | 49 ± 11.78 | 0.117 |
| Pre-menopausal | 60 (44.1) | 103 (48.8) | 0.392 | 20 (54.1) | 0.282 |
| Post-menopausal | 76 (55.9) | 108 (51.2) | 17 (45.9) | ||
| Nulliparous | 20 (14.7) | 39 (18.5) | 0.360 | 11 (29.7) | 0.035 |
| Multiparous | 116 (85.3) | 172 (81.5) | 26 (70.3) | ||
| Without AUB | 126 (92.6) | 193 (91.5) | 0.694 | 25 (67.6) | < 0.001 |
| With AUB | 10 (7.4) | 18 (8.5) | 12 (32.4) | ||
| Histological ovary type | |||||
| Serous | 124 (91.2) | 111 (52.6) | < 0.001 | 15 (40.5) | < 0.001 |
| Mucinous | 3 (2.2) | 18 (8.5) | 2 (5.4) | ||
| Endometrioid | 7 (5.1) | 54 (25.6) | 17 (45.9) | ||
| Clear cell | 1 (0.7) | 19 (9) | 2 (5.4) | ||
| Unknown | 0 | 2 (0.9) | 1 (2.7) | ||
| Mixed | 1 (0.7) | 7 (3.3) | 0 | ||
| Ovary tumor stage | |||||
| 1 | 0 | 119 (56.4) | < 0.001 | 21 (56.8) | < 0.001 |
| 2 | 19 (14) | 23 (10.9) | 2 (5.4) | ||
| 3 | 109 (80.1) | 69 (32.7) | 14 (37.8) | ||
| 4 | 8 (5.9) | 0 | 0 | ||
| Ovary tumor grade | |||||
| 1 | 19 (14) | 63 (29.9) | 0.008 | 13 (35.1) | 0.003 |
| 2 | 32 (23.5) | 44 (20.9) | 11 (29.7) | ||
| 3 | 76 (55.9) | 93 (44.1) | 9 (24.3) | ||
| Unknown | 9 (6.6) | 11 (5.2) | 4 (10.8) | ||
| CA125 | |||||
| < 35 | 6 (4.7) | 26 (14.7) | 0.005 | 3 (9.4) | 0.303 |
| > 35 | 122 (95.3) | 151 (85.3) | 29 (90.6) | ||
| CA125 | |||||
| < 100 | 22 (17.2) | 66 (37.3) | < 0.001 | 11 (34.4) | 0.032 |
| > 100 | 106 (82.8) | 111 (62.7) | 21 (65.6) | ||
ametastatic uterine involvement and other epithelial ovarian cancer comparison, b metastatic uterine involvement and synchronous endometrial disorder comparison